225 related articles for article (PubMed ID: 23839233)
21. Loss of discoidin domain receptor 1 (DDR1) via CpG methylation during EMT in epithelial ovarian cancer.
Chung VY; Tan TZ; Huang RL; Lai HC; Huang RY
Gene; 2017 Nov; 635():9-15. PubMed ID: 28887161
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
[TBL] [Abstract][Full Text] [Related]
23. A novel genome-based approach correlates TMPRSS3 overexpression in ovarian cancer with DNA hypomethylation.
Guerrero K; Wang Z; Bachvarova M; Gregoire J; Renaud MC; Plante M; Bachvarov D
Gynecol Oncol; 2012 Jun; 125(3):720-6. PubMed ID: 22446619
[TBL] [Abstract][Full Text] [Related]
24. DNA hypomethylation-mediated overexpression of carbonic anhydrase 9 induces an aggressive phenotype in ovarian cancer cells.
Sung HY; Ju W; Ahn JH
Yonsei Med J; 2014 Nov; 55(6):1656-63. PubMed ID: 25323905
[TBL] [Abstract][Full Text] [Related]
25. Hypermethylation and post-transcriptional regulation of DNA methyltransferases in the ovarian carcinomas of the laying hen.
Lee JY; Jeong W; Lim W; Lim CH; Bae SM; Kim J; Bazer FW; Song G
PLoS One; 2013; 8(4):e61658. PubMed ID: 23613894
[TBL] [Abstract][Full Text] [Related]
26. Peperomin E Induces Promoter Hypomethylation of Metastatic-Suppressor Genes and Attenuates Metastasis in Poorly Differentiated Gastric Cancer.
Wanga XZ; Gu JL; Gao M; Bian Y; Liang JY; Wen HM; Wu H
Cell Physiol Biochem; 2018; 50(6):2341-2364. PubMed ID: 30423554
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules.
Kelly TK; Liu Y; Lay FD; Liang G; Berman BP; Jones PA
Genome Res; 2012 Dec; 22(12):2497-506. PubMed ID: 22960375
[TBL] [Abstract][Full Text] [Related]
28. Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling.
Sarkar S; Abujamra AL; Loew JE; Forman LW; Perrine SP; Faller DV
Anticancer Res; 2011 Sep; 31(9):2723-32. PubMed ID: 21868513
[TBL] [Abstract][Full Text] [Related]
29. The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation.
Sernbo S; Gustavsson E; Brennan DJ; Gallagher WM; Rexhepaj E; Rydnert F; Jirström K; Borrebaeck CA; Ek S
BMC Cancer; 2011 Sep; 11():405. PubMed ID: 21943380
[TBL] [Abstract][Full Text] [Related]
30. Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells.
Pandey M; Shukla S; Gupta S
Int J Cancer; 2010 Jun; 126(11):2520-33. PubMed ID: 19856314
[TBL] [Abstract][Full Text] [Related]
31. Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-specific and global DNA methylation status in ovarian cancer.
Woloszynska-Read A; Mhawech-Fauceglia P; Yu J; Odunsi K; Karpf AR
Clin Cancer Res; 2008 Jun; 14(11):3283-90. PubMed ID: 18519754
[TBL] [Abstract][Full Text] [Related]
32. DNA methyltransferase 3a and mitogen-activated protein kinase signaling regulate the expression of fibroblast growth factor-inducible 14 (Fn14) during denervation-induced skeletal muscle atrophy.
Tajrishi MM; Shin J; Hetman M; Kumar A
J Biol Chem; 2014 Jul; 289(29):19985-99. PubMed ID: 24895120
[TBL] [Abstract][Full Text] [Related]
33. Novel miRNA genes deregulated by aberrant methylation in ovarian carcinoma are involved in metastasis.
Loginov VI; Pronina IV; Burdennyy AM; Filippova EA; Kazubskaya TP; Kushlinsky DN; Utkin DO; Khodyrev DS; Kushlinskii NE; Dmitriev AA; Braga EA
Gene; 2018 Jul; 662():28-36. PubMed ID: 29631007
[TBL] [Abstract][Full Text] [Related]
34. Protein arginine methyltransferase 5 functions as an epigenetic activator of the androgen receptor to promote prostate cancer cell growth.
Deng X; Shao G; Zhang HT; Li C; Zhang D; Cheng L; Elzey BD; Pili R; Ratliff TL; Huang J; Hu CD
Oncogene; 2017 Mar; 36(9):1223-1231. PubMed ID: 27546619
[TBL] [Abstract][Full Text] [Related]
35. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
[TBL] [Abstract][Full Text] [Related]
36. Aldosterone reprograms promoter methylation to regulate αENaC transcription in the collecting duct.
Yu Z; Kong Q; Kone BC
Am J Physiol Renal Physiol; 2013 Oct; 305(7):F1006-13. PubMed ID: 23926181
[TBL] [Abstract][Full Text] [Related]
37. RFTS-dependent negative regulation of Dnmt1 by nucleosome structure and histone tails.
Mishima Y; Brueckner L; Takahashi S; Kawakami T; Arita K; Oka S; Otani J; Hojo H; Shirakawa M; Shinohara A; Watanabe M; Suetake I
FEBS J; 2017 Oct; 284(20):3455-3469. PubMed ID: 28834260
[TBL] [Abstract][Full Text] [Related]
38. Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells.
Andreu-Vieyra C; Lai J; Berman BP; Frenkel B; Jia L; Jones PA; Coetzee GA
Mol Cell Biol; 2011 Dec; 31(23):4648-62. PubMed ID: 21969603
[TBL] [Abstract][Full Text] [Related]
39. Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis.
Guenin S; Mouallif M; Deplus R; Lampe X; Krusy N; Calonne E; Delbecque K; Kridelka F; Fuks F; Ennaji MM; Delvenne P
PLoS One; 2012; 7(8):e42704. PubMed ID: 22880087
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-29b contributes to DNA hypomethylation of CD4+ T cells in systemic lupus erythematosus by indirectly targeting DNA methyltransferase 1.
Qin H; Zhu X; Liang J; Wu J; Yang Y; Wang S; Shi W; Xu J
J Dermatol Sci; 2013 Jan; 69(1):61-7. PubMed ID: 23142053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]